Market Research Report
July 22, 2019

Spatial Genomics and Transcriptomics Market Size, Share | Industry Report, 2026

The Global Spatial Genomics and Transcriptomics Market is estimated to cross Market Size of US$ 270 Million by 2026 with a CAGR of 8.7% during the forecast period 2019 to 2026.

The Spatial Genomics and Transcriptomics Market By Market Analysis, Market Size, Opportunities, Revenue Status, Business Development and Forecast, 2019 to 2026 report has been added to Acumen Research and Consulting's offers.

The report analyzes and forecasts the Spatial Genomics and Transcriptomics Market at global and regional levels. The market has been forecast based on volume (Unit) and value (US$) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

Download Free Sample Report Pages at https://www.acumenresearchandconsulting.com/request-sample/1532

The study provides a decisive view of the market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Players:

Some of the key participants operating in this market are NanoString Technologies; 10x Genomics; CARTANA AB; Horizon Discovery Group plc; Illumina, Inc.;S2 Genomics, Inc.; Dovetail Genomics; Seven Bridges Genomic; and Advanced Cell Diagnostics.

The Major Market Segments of Global Spatial Genomics and Transcriptomics Market are as below:

Market Segmentation

Global Spatial Genomics & Transcriptomics Market, By Technology


  • Spatial Transcriptomics


    Sequencing-Based Methods

    In Situ Sequencing
    Laser Capture Microdissection (LCM)
    Microtomy Sequencing
    Transcriptome In-Vivo Analysis (TIVA)



    Microscopy-based RNA Imaging Techniques

    Padlock Probes/ Rolling Circle Amplification
    Single Molecule RNA Fluorescence In-Situ Hybridization
    Branched DNA Probes


    IHC


  • Spatial Genomics

    Microscopy-based Live DNA Imaging
    FISH
    Massively-Parallel Sequencing
    Genome Perturbation Tools
    Biochemical Techniques
    Others

Global Spatial Genomics & Transcriptomics Market, By Product


Instruments

By Type

IHC
Sequencing Platforms
Mass Spectrometry
Microscopy
Flow Cytometry
Others

By Mode

Manual
Semi-automated
Automated
Software
Imaging Tools
Bioinformatics Tools
Storage and Management Databases

Consumables

Global Spatial Genomics & Transcriptomics Market, By End-Use

  • Pharmaceutical Manufacturer
  • Academic Customers
  • Translational Research
  • Diagnostic Customers

Global Spatial Genomics & Transcriptomics Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Spatial Genomics and Transcriptomics Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Spatial Genomics & Transcriptomics market segments with market dynamics and their impact. The report also covers basic technology development policies.

View Detail Information with Complete TOC at https://www.acumenresearchandconsulting.com/spatial-genomics-and-transcriptomics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Spatial Genomics and Transcriptomics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Spatial Genomics and Transcriptomics Market By Technology
1.2.2.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Spatial Genomics and Transcriptomics Market Revenue Share By Technology in 2017
1.2.2.3. Spatial Transcriptomics
1.2.2.3.1. Sequencing-Based Methods
1.2.2.3.1.1. In Situ Sequencing
1.2.2.3.1.2. Laser Capture Microdissection (LCM)
1.2.2.3.1.3. Microtomy Sequencing
1.2.2.3.1.4. Transcriptome In-Vivo Analysis (TIVA)
1.2.2.3.2. Microscopy-based RNA Imaging Techniques
1.2.2.3.2.1. Padlock Probes/ Rolling Circle Amplification
1.2.2.3.2.2. Single Molecule RNA Fluorescence In-Situ Hybridization
1.2.2.3.2.3. Branched DNA Probes
1.2.2.3.3. IHC
1.2.2.4. Spatial Genomics
1.2.2.4.1. Microscopy-based Live DNA Imaging
1.2.2.4.2. FISH
1.2.2.4.3. Massively-Parallel Sequencing
1.2.2.4.4. Genome Perturbation Tools
1.2.2.4.5. Biochemical Techniques
1.2.2.4.6. Others
1.2.3. Spatial Genomics and Transcriptomics Market By Product
1.2.3.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Instruments
1.2.3.2.1. By Type
1.2.3.2.1.1. IHC
1.2.3.2.1.2. Sequencing Platforms
1.2.3.2.1.3. Mass Spectrometry
1.2.3.2.1.4. Microscopy
1.2.3.2.1.5. Flow Cytometry
1.2.3.2.1.6. Others
1.2.3.2.2. By Mode
1.2.3.2.2.1. Manual
1.2.3.2.2.2. Semi-automated
1.2.3.2.2.3. Automated
1.2.3.3. Software
1.2.3.3.1. Imaging Tools
1.2.3.3.2. Bioinformatics Tools
1.2.3.3.3. Storage and Management Databases
1.2.3.4. Consumables
1.2.4. Spatial Genomics and Transcriptomics Market By End-Use
1.2.4.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.4.2. Pharmaceutical Manufacturer
1.2.4.3. Academic Customers
1.2.4.4. Translational Research
1.2.4.5. Diagnostic Customers
1.2.4.6. Others
1.2.5. Spatial Genomics and Transcriptomics Market by Geography
1.2.5.1. Global Spatial Genomics and Transcriptomics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Spatial Genomics and Transcriptomics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Spatial Genomics and Transcriptomics Major Manufacturers in 2017

CHAPTER 4. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TECHNOLOGY

4.1. Global Spatial Genomics and Transcriptomics Revenue By Technology
4.2. Spatial Transcriptomics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Sequencing-Based Methods
4.2.3.1. In Situ Sequencing
4.2.3.2. Laser Capture Microdissection (LCM)
4.2.3.3. Microtomy Sequencing
4.2.3.4. Transcriptome In-Vivo Analysis (TIVA)
4.2.4. Microscopy-based RNA Imaging Techniques
4.2.4.1. Padlock Probes/ Rolling Circle Amplification
4.2.4.2. Single Molecule RNA Fluorescence In-Situ Hybridization
4.2.4.3. Branched DNA Probes
4.2.5. IHC
4.3. Spatial Genomics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Microscopy-based Live DNA Imaging
4.3.4. FISH
4.3.5. Massively-Parallel Sequencing
4.3.6. Genome Perturbation Tools
4.3.7. Biochemical Techniques
4.3.8. Others

CHAPTER 5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY PRODUCT

5.1. Global Spatial Genomics and Transcriptomics Revenue By Product
5.2. Instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. By Type
5.2.3.1. IHC
5.2.3.2. Sequencing Platforms
5.2.3.3. Mass Spectrometry
5.2.3.4. Microscopy
5.2.3.5. Flow Cytometry
5.2.3.6. Others
5.2.4. By Mode
5.2.4.1. Manual
5.2.4.2. Semi-automated
5.2.4.3. Automated
5.3. Software
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3.3. Imaging Tools
5.3.4. Bioinformatics Tools
5.3.5. Storage and Management Databases
5.4. Consumables
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USE

6.1. Global Spatial Genomics and Transcriptomics Revenue By End-Use
6.2. Pharmaceutical Manufacturer
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Academic Customers
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Translational Research
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Diagnostic Customers
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

7.1. North America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Spatial Genomics and Transcriptomics Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

8.1. Europe Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

9.1. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

10.1. Latin America Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

11.1. Middle East Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY COUNTRY

12.1. Africa Spatial Genomics and Transcriptomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Spatial Genomics and Transcriptomics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. NanoString Technologies
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. 10x Genomics
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. CARTANA AB
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Horizon Discovery Group plc
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Illumina, Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. S2 Genomics, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Dovetail Genomics
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Seven Bridges Genomic
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Advanced Cell Diagnostics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1532

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.